United States· US:0245-6001_2734e899-4ddc-836c-e063-6294a90a128f

VIGADRONE

A vigabatrin product containing vigabatrin, registered in United States by Upsher-Smith Laboratories, LLC. The same ATC class is registered in 17 of our 19 countries.

ATC N03AG04US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about vigabatrinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vigabatrin is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AG04 (vigabatrin), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
10 of them publish a price we can compare per daily dose

Search vigabatrin products by name

Vigabatrin · ATC N03AG04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vigabatrin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $3.20 in Italy to $12.93 in France — a ×4.0 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Vigabatrin · price per daily dose (2 g)

USD · FX 28 Sept 2026

FR France$12.93
CH Switzerland$3.45
IT Italy$3.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: VIGABATRIN
Manufacturer: Upsher-Smith Laboratories, LLC
Country: United States (US)
ATC code: N03AG04
ATC class: Vigabatrin
Defined daily dose: 2 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
0245600111
1 BOTTLE in 1 CARTON (0245-6001-11) / 100 TABLET in 1 BOTTLE
ndc11
0245-6001-11

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

115 interactions on record for vigabatrin.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check vigabatrin against other medicines How interaction checks work

Vigabatrin · interactions on record

115 records

31 severe
59 moderate

Most severe, free to view

OxyquinolineA01AB07severe
PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe

25 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vigabatrin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vigabatrin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Austria · Sabril
Belgium · Sabril
Czechia · Sabril
Germany · Sabril, Sabril Beutel
Denmark · Sabrilex
Spain · Sabrilex, Vigzip
Finland · Sabrilex
France · Sabril, Vigzip
United Kingdom (Northern Ireland) · Sabril, Vigabatrin Zydus Pharmaceuticals Uk
Greece · Sabril
Hungary · Sabril
Ireland · Sabril
Iceland · Kigabeq, Sabrilex
Italy · Sabril, Vigzip
Liechtenstein · Kigabeq
Luxembourg · Sabril
Netherlands · Sabril, Sabril Filmomhulde Tablet
Norway · Kigabeq, Sabrilex
Poland · Sabril
Portugal · Sabril
Sweden · Sabrilex
Slovenia · Sabril
Slovakia · Sabril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/acf94141-2dd1-4dbb-8e1c-f0bceb9f37ba
GET /v1/drugs/acf94141-2dd1-4dbb-8e1c-f0bceb9f37ba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "VIGABATRIN",
  "productndc": "0245-6001",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA214749",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about vigabatrin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console